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The plant Cassia auriculata L. belonging to the family Caesalpiniaceae (Leguminosae) used in the Ayurvedic system of 
medicine for the treatment of diabetes, ulcers, leprosy, conjunctivitis, liver and skin diseases. The present study aimed to 
evaluate the antipsoriatic effect of the ointments 0.5 and 1.0% (w/w) containing ethanol extract of the flowers of  
C. auriculata using complete Freund's adjuvant (CFA) and induced animal model and also evaluated for its physical 
parameters. Antipsoriatic effect of 0.5 and 1.0% (w/w) ointments was evaluated by the phenotypic features (redness, 
erythema, and scales) in terms of psoriasis severity index (PSI) and histological features (epidermal thickness and degree of 
orthokeratosis). Evaluation of physical parameters for the prepared ointments showed satisfactory results with an acceptable 
condition of consistency for application. 0.5 and 1.0% (w/w) ointments treated animals showed a significant (*P <0.05) 
increase in the orthokeratinocyte layer and a significant (**P <0.01) reduction in the epidermal layer of skin treated with 
1.0% (w/w) ointment with a progressive reduction (**P <0.01) in the severity of psoriatic lesions (erythema, redness, and 
scales) from day 7 to 21st day. The present investigations revealed that the flowers of Cassia auriculata possess antipsoriatic 
activity, confirming their traditional use in skin disorders.   
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Introduction 
Psoriasis is an inflammatory disease of the skin that 
affects as many as 125 million people worldwide. It is 
characterized by pink colour plaques and white flaky 
skin due to increased levels of pro-inflammatory 
cytokines and over-proliferation of keratinocytes at the 
basal layer of the epidermis1. As psoriasis is an immune-
disorder, also associated with overexpression of  
pro-inflammatory cytokines and abnormal proliferation 
of keratinocytes, the therapeutic agents that may be able 
to inhibit proliferation of psoriatic keratinocytes or able 
to modulate the immune system are suggested for 
treating psoriasis2. For many people with psoriasis, 
existing treatments are not effective, appropriate or may 
not be accessible due to cost. As herbal formulations are 
considered to be less expensive with minimal side 
effects, a review by Deng et. al. highlighted possible 
alternative medicine for the treatment of psoriasis3. 
Generally, Cassia species are well known for their 
laxative and purgative constituents and are also used 
for the cure of skin diseases. Cassia auriculata L. 
(Caesalpinaceae), commonly known as Tanners 
Senna, is a common, highly branched shrub with  
large bright yellow flowers distributed wildly in  
dry regions of the central provinces and  
western peninsula of India4. The plant as a whole  
has been extensively used in Ayurvedic and  
Siddha practice as antidiabetic, antidysenteric, 
antimicrobial and for various skin diseases  
from ancient times5-7. Therefore, in light of 
ethnopharmacological facts of the plant, to validate  
its use in skin diseases scientifically, an attempt  
has been made to investigate the therapeutic  
potential of ethanolic extract of C. auriculata flowers 
in chronic inflammatory skin disease, psoriasis in 
Complete Freund’s adjuvant (CFA) and 
formaldehyde-induced psoriatic model. 
 
Materials and Methods 
Plant materials  
The plant specimen for the proposed study were 
collected in the month of November 2018 from 
Kancheepuram, Tamil Nadu and authenticated by  
Dr. P. Jayaraman, Director, Plant Anatomy Research 
—————— 
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Center, (PARC) Tambaram and Chennai. A voucher 
specimen No. PARC/2017/2155 has been deposited 
for future references.  
 
Extraction 
The flowers of C. auriculata were isolated and 
subjected to drying followed by grinding. To remove 
fatty materials, the coarse powder was extracted with 
petroleum ether (60-80 °C) for 72 hours, followed by 
extraction using a Soxhlet apparatus with 95% ethanol 
for 36 hours. The collected ethanol extract was filtered 
and concentrated using a rotary vacuum flash 
evaporator in a vacuum under reduced pressure8. The 
dried extract was stored in an airtight container at 4 °C 
and the percentage yield of the ethanol extract was 
noted.  
 
Phytochemical analysis   
The ethanol extract was subjected to preliminary 
phytochemical analysis for the identification of 
various phytochemical constituents present using 
standard methods9. 
 
Thin-layer chromatography (TLC) 
To support preliminary chemical analysis, the 
ethanolic extract was subjected to TLC study. A 
number of developing solvent systems were tried, but 
the satisfactory resolution was obtained in the solvent 
system Toluene:Ethyl acetate:Formic acid (5:4:1). 
After developing, the plates were air-dried and 
exposed to iodine vapour. 
 
Formulation of ointment  
Topical therapy is the standard of care for 
treatment of mild to moderate disease. A large 
proportion of patients would benefit from topical 
therapy, which can be initiated at the primary care 
level10. Hence, herbal ointment containing ethanol 
extract of C. auriculata (0.5 and 1.0% w/w) was 
prepared using wool fat, hard paraffin, yellow soft 
paraffin and cetosteryl alcohol as oleaginous phase 
and extract, glycerin and water as the aqueous phase 
as per the formula in Table 1. The oleaginous base 
was prepared by heating the wool fat, hard paraffin 
and the cetosteryl alcohol at 70 oC. The aqueous phase 
was prepared by boiling the extract, glycerin and the 
water at 70 oC. On reaching 70 oC the aqueous phase 
was slowly added to the oleaginous phase with 
continuous stirring and was left to cool11.  
 
Evaluation of ointment 
 The physical parameters such as the colour of the 
ointment, pH, viscosity of the ointment, spreadability 
and washability were evaluated as per standard 
procedure12.  
 
Animals 
Adult Swiss albino mice weighing about 25±2 g of 
age 10 weeks were obtained from the Institutional 
Animal house. Animals were housed in polypropylene 
cages and were acclimatized under controlled condition 
(a 12 h light-dark cycle at 22±2 oC) on standard pellet 
diet and water ad libitum for 7 days. As per the 
guidelines of CPCSEA, all animals were maintained 
with due approval from the Institutional Animal Ethics 
Committee (IAEC). The protocol was approved by the 
IAEC (No. XXI/VELS/PCOL/14/2000/CPCSEA/IAEC/ 
01.12.2017).  
 
Acute dermal toxicity 
According to the Organization for Economic 
Cooperation and Development guidelines (402), the 
acute dermal toxicity of the formulated herbal 
ointments was evaluated. Swiss albino mice were 
divided into two groups, each group consisting of  
6 animals. Hairs were shaved on the 10% dorsal 
surface of the animal body 24 hours prior to the test. 
The 0.05 and 0.1% (w/w) of formulated ointments of 
dose 200 mg/kg body weight was applied on the 
shaved area topically. The treated animals of both 
groups were monitored for 14 days for redness, 
erythema, and changes in fur, sleep pattern, behaviour 
pattern, and mortality13. 
 
Evaluation of anti-psoriatic activity 
Complete Freund's adjuvant and formaldehyde induced model - 
Psoriasis induction  
A mixture of CFA and formaldehyde in the 
proportion of 1:10 ratio was prepared. Using 
depilatory cream, hairs on the dorsal region (2 cm × 2 
cm) were removed (Reckitt Benckiser, Inc., UK) from 
the animal. About 0.1 mL of the prepared mixture was 
applied on the shaved area topically of all test animals 
(n = 10), for 3 days. 
Table 1 — Formulation of ointment 
S. No Ingredients Quantity for  
0.5% w/w 
Quantity for 
1.0% w/w 
1 Yellow soft paraffin 26.45g 26.45g 
2 Hard Paraffin 26.45g 26.45g 
3 Wool Fat 21.45g 21.45g 
4 Cetosteryl alcohol 10.15g 10.1g 
5 Water 5 mL 5 mL 
6 Glycerine 10 mL 10 mL 
7 Ethanolic Extract 0.5% 1.0% 
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Psoriasis induced animals were observed for the 
presence of psoriatic lesions for 7 days daily. Based 
on the psoriasis area clinically and severity index, an 
objective scoring system was developed. Redness, 
erythema, and scales were scored independently on a 
scale from 0 to 4: 0-none; 1-slight; 2-moderate;  
3- marked; and 4-very marked. Psoriasis severity 
index (PSI) was measured in terms of the cumulative 
score (sum of redness, erythema, and scaling)  
(scale 0 – 12). Animals were anaesthetized using 
ketamine at the end of the study, skin specimen was 
collected and preserved in glass vials containing 10% 
formalin solution and subjected to histological 
examination. Longitudinal sections of mice skin 
specimen (about 5 μm thickness) were prepared by 
microtomy and stained with hematoxylin (H) and 
eosin (E) dye for histological examination14. 
 
Antipsoriatic activity of the prepared herbal ointment 
A mixture of CFA and formaldehyde (1:10 ratio) 
was applied topically to induce Psoriasis.  All the 
animals were re-randomized before treatment to 
reduce the error in mean PSI between the groups after 
the induction. Psoriasis induced animals were divided 
into four groups of 6 each (n = 6). Group I 
(Untreated), Group II (Positive control) treated with 
Retino-A cream (0.05%), Group III and IV were 
treated with 0.05 and 0.1% (w/w) of prepared 
ointments, respectively. Animals were treated with 
the ointment after induction of psoriasis for 3 weeks 
once daily. Antipsoriatic effect of the ointment was 
evaluated in terms of the severity of psoriatic lesions 
score every week indicating the reduction in the 
psoriatic symptoms.  
Increase in percentage of orthokeratotic regions 
indicates drug activity. Presence of a granular layer 
induced was examined in 10 sequential scales which 
show previously parakeratotic skin areas. The induction 
of orthokeratosis, which have normally a parakeratotic 
differentiation in psoriatic condition, was quantified by 
measuring the length of the granular layer (A) and the 
length of the scale (B). The proportion (A/B)×100 
represents the % orthokeratosis per scale, and the drug 
activity (DA) was calculated as follows:  
 
mean OK of treated group mean OK of control group 100DA
100 mean OK of control group
            
      
     
 
where OK = orthokeratosis.   
The measurements were carried out at the border of 
the scale with a semiautomatic image evaluation unit15.  
Histological examination  
After treatment with the prepared ointment, the 
animals were subjected to ketamine overdose and the 
dorsal skin part was removed and stored in 4% formalin. 
Then the skin samples were given for histopathological 
study which was performed using eosin stain and 
haematoxylin. It was obtained by measuring the distance 
between the dermo-epidermal borderline and the 
beginning of the horny layer. Five measurements per 
animal were made in every 10 scales.  
 
Statistical analysis  
Values were represented as mean±SEM. Data were 
analyzed using one-way analysis of variance 
(ANOVA) and group means were compared using the 
Tukey-Kramer Multiple Comparison test using Instat-
V3 software. P values <0.05 were considered 
significant. 
 
Results and Discussion 
Preliminary phytochemical screening  
The percentage yield of ethanol extract of  
C. auriculata was found to be 10.20% w/w. The 
qualitative phytochemical analysis of the extract 
showed the presence of flavonoids, alkaloids, tannins, 
glycosides, terpenoids, phenols, carbohydrates,  
and proteins.  
 
Thin-layer chromatography  
The TLC studies of the ethanol extract of Cassia 
auriculata showed the presence of well-separated  
6 cleared spot with the Rf values of range 0.07-0.89.  
 
Formulation of herbal ointment  
Simple ointment 0.5 and 1.0% (w/w) containing 
the ethanol extract of C. auriculata was prepared as 
per the formula given in Table 1.  
 
Evaluation of formulated herbal ointment  
The prepared ointment containing ethanol extract 
of C. auriculata was evaluated for various physico-
chemical parameters. The pH of the ointment lies 
within the normal pH range of the human skin 
(6.8±1). The prepared ointments, when applied over 
the animal skin for a week, did not produce any skin 
irritation in terms of erythema and oedema. 
Spreadability of the prepared ointments was found to 
be in the range 6.5 to 6.6, revealing an easy in 
spreading over the skin and therefore the active 
ingredient in the ointment would be released for a 
local effect. In general, all formulations met the 
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acceptable conditions of consistency for application. 
The results are shown in Table 2. 
 
Antipsoriatic activity 
Induction of psoriasis 
Psoriasis was induced in mice by applying 0.1 mL 
of the mixture of CFA and formaldehyde for 7 days 
on the dorsal portion of the animal. On the 7th day of 
induction, silvery scales, erythema and redness were 
observed on exposed area and the severity increased 
progressively. On the 7th day of psoriatic induction, 
the cumulative score, PSI was significantly  
(*P <0.05) increased (Fig. 1). 
Histological examination of psoriasis induced in 
mouse skin by the topical application of CFA and 
formaldehyde exhibited several pro-inflammatory 
reactions such as redness, erythema, scales, 
elongation of rete ridges, presence of Munro's 
microabscess and dilatation of capillary loop, 
increased epidermal thickness, keratinocytes 
proliferation and absence of the granular layer 
(parakeratosis) when compared with normal animal 
skin (Plate 1). All these phenotypic and histological 
features in mice resemble a sign of psoriatic lesions in 
human plaque psoriasis.  
 
Effect of test formulations on complete freund's adjuvant and 
formaldehyde-induced psoriasis 
Ointments 0.5 and 1.0% (w/w) containing ethanol 
extract of C. auriculata extract were applied once daily 
for 3 weeks in psoriasis induced animals and the severity 
of psoriatic lesions was calculated by visual and 
histological examinations. In untreated animal group 
(Group I), the severity of psoriatic lesions was gradually 
increased when examined visually throughout the 
experimental period and cumulative score (PSI) was 
increased manifold on 21st day when compared with 
other groups. In standard group of animals (Group II), 
topical application of standard drug Retino-A cream 
(0.05%) reduced the severity of psoriatic lesions and 
cumulative score progressively (**P <0.01) from day 7 
to 21st day confirming the therapeutic effect of a 
standard drug, retinoid a derivative of vitamin A on 
 
 
Fig. 1 — Effect of herbal ointment containing ethanol extract of Cassia auriculata on the redness, erythema, scales and cumulative score 
in CFA-formaldehyde induced model. Values are mean±SEM of 6 parallel measurements. Data were analyzed by one-way ANOVA 
followed by Tukey Kramer multiple comparison test. The values are *P <0.05; **P <0.01 when compared against control.
Table 2 — Physical evaluation of formulated ointment 
Physico-chemical 
parameters 
Observation  
(0.5% w/w) 
Observation  
(1.0% w/w) 
Colour Yellow Brown 
Odour Characteristic Characteristic 
pH 6.7 6.8 
Consistency Smooth Smooth 
Spreadability 6.5 6.6 
Washability Good Good 
Non irritancy Non irritant Non irritant 
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psoriatic lesions reduces inflammation by reducing the 
formation of cytokines and interleukins. Animals treated 
with 0.5% (w/w) ointment (Group III), showed a gradual 
decrease in redness, erythema, scales (psoriatic lesions) 
and a significant reduction (**P <0.01) in the 
cumulative score when compared with control group. 
Animals treated with 1% (w/w) ointment (Group IV), 
showed a significant reduction (**P <0.01) in redness, 
erythema, scales and cumulative score (Fig. 1). 
Animals treated with standard drug (Group II) has 
increased the orthokeratotic regions significantly  
(*P <0.05) by 60.97% and animals treated treated 
with 0.5 and 1.0% w/w ointment (Group III and IV) 
containing ethanol extract of C. auriculata flowers 
has increased the orthokeratotic regions by 28.04 and 
43.90% respectively in comparison to control group. 
Increased epidermal thickness (approximately 2 fold 
increase) was observed in control group, whereas the 
group treated with standard showed significant  
(**P <0.01) decrease in epidermal thickness. Among 
the tested ointment, 1.0% w/w treated group showed 
significant (**P <0.01) decrease in epidermal 
thickness indicating reduced parakeratosis, retention 
of  granular layer, reduced hyperproliferation of 
keratinocytes and initiation of keratinization process. 
The results were shown in Plate 2 and Table 3. 
 
 
Plate 1 — Longitudinal histological sections of mouse skin (H and E, ×40), a) section of normal mouse skin and b) section of complete 
Freund's adjuvant- and formaldehyde-treated mouse skin. 
 
 
 
Plate 2 — Longitudinal histological sections of mouse skin of different groups (H and E, ×40). 
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The psoriatic lesions in early stage are characterized 
by intraepidermal penetration of activated 
polymorphonuclear leukocytes that leads to the 
uncontrolled production of reactive oxygen species 
causing peroxidative damage to the skin membranes 
which leads to the exacerbation of psoriatic lesions. 
Reactive oxygen species activate phospholipase A2 
and increases arachidonic acid mediators release. 
Psoriasis is also contributed by the production of 
prostaglandin E2 by the cyclooxygenase pathway 
through dilating capillaries in the dermis, increasing 
infiltration of leukocyte and stimulating the growth of 
keratinocyte cell16. Flavonoids, triterpenoids, and 
polyphenolic compounds are well known for their 
potential antioxidant effect and for their 
immunomodulatory, anti-inflammatory, anti 
proliferative, and free radical scavenging activities17. 
Hence, polyphenolic phytoconstituents may be 
beneficial for the treatment of diseases with multiple 
etiologies such as psoriasis. Preliminary phytochemical 
analysis of the C. auriculata flowers showed the 
presence of the rich amount of polyphenols and 
flavonoids, which may be responsible for their 
protective role in the management of psoriasis and may 
be due to the synergistic effect of phytoconstituents. 
The results of the present study support the use of 
Cassia auriculata in traditional Indian medicine and 
can be used as an easily accessible natural source for 
treating psoriasis, a chronic inflammatory skin disease. 
 
Conclusion 
The ethanol extract of the flowers of Cassia 
auriculata was evaluated for antipsoriatic activity in 
complete Freund’s adjuvant and formaldehyde 
induced animal model. After induction of psoriasis, 
the animals were treated with the ointment (0.5% and 
1% w/w) containing ethanol extract of Cassia 
auriculata flowers and the prepared ointment 
alleviated the sign of psoriasis along with mean PSI, 
which may be due to the presence of the polyphenols 
(flavonoids and tannins). Hence, we conclude that the 
plant Cassia auriculata flowers possesses 
antipsoriatic activity which is in agreement with its 
traditional use.  
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